GLG News by Physicians who Perform Procedures using MammoSite

Standard breast conserving therapy consists of breast conserving surgery followed by whole breast radiotherapy (to a dose of 45-50.4Gy), followed by a boost to the lumpectomy site of 10-16Gy for a total dose of 61-66Gy.    The boost is typically done after the completion of whole breast...

CMS's latests decision to not reimburse hospitals for medical errors and hospital acquired infections has been widely discussed on these newsgroups.   Simpy put, while medical errors and infections are unfortunate and can have adverse consequences, the key here is which of these events could...

ASA404 is a small-molecule vascular disrupting agent that selectively disrupts established tumour blood vessels, in theory allowing chemotherapy to reach tumor cells. The data to date in NSCLC is quite promising, with significant increases in overall and medial survival when combined with...

In the modern era of medicine, where documentation and communication is important, fast turn around of dictated reports (radiology, consultation, progress notes) is important for an efficient workflow. Speech recognition software has improved dramatically over the last decade, allowing for relatively...

Pay for performance is here, and being used in actual reimbursements.    This is an example of this in the private payor model.

Taxotere with prednisone is the standard first line chemotherapy for hormone refractory prostate cancer based on the results of the TAX 327 trial.   The ongoing phase II trial looks to see if the addition of a platinum based agent to taxotere improves outcomes in hormone refractory prostate...

Cytopias new agent CY997 has met it's phase I goal to determine MTD and DLT - not a hard task to have done.   Either it's tolerable and safe or not tolerable and not safe.   In this case, the former holds true. However, without more significant clinical data - phase II and III -...

Well....we know CMS doesn't have enough money to fund healthcare in perpetuity.   Physicians have been taking reimbursement cuts or lack of raises over the last 5 years.    Realizing you can't squezze enough money out of the physicians, Medican now brilliantly plans to...

Glioblastomas and diffuse pontine gliomas in adults and children are agressive, and nearly universally fatal.  The standard of care today for GBMs is concurrent chemoradiotherapy with Temodar, based on the results of the NCIC trial (Stupp, et al., NEJM, 352:987-96, 2005).   For diffuse...

There are many theories out there about how angiogenesis affects tumor growth.   One theory is that anti-angiogenic agents emilinate the leakiness of blood vessels, improving flow of blood and chemotherapy to the tumor, essentially getting more of a cytotoxic agent to the target. SPI-1620...